Channelling treatment for neuropathic pain.
Hayward
Peter
P
D000818:Animals; D062552:NAV1.3 Voltage-Gated Sodium Channel; D009419:Nerve Tissue Proteins / Q000502:physiology*; D009474:Neurons / Q000502:physiology; D010146:Pain / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D010523:Peripheral Nervous System Diseases / Q000150:complications* / Q000503:physiopathology; D051381:Rats; D026941:Sodium Channel Blockers / Q000627:therapeutic use*; D015222:Sodium Channels / Q000502:physiology*; D013119:Spinal Cord Injuries / Q000150:complications
D062552:NAV1.3 Voltage-Gated Sodium Channel; D009419:Nerve Tissue Proteins; C424715:SCN3A protein, human; D026941:Sodium Channel Blockers; D015222:Sodium Channels